PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Oct-2023 Trinity Life Sciences Introduces Launch Accelerator 2.0, the First and Only Benchmark-Based Launch Tool for Pharma Trinity Life Sciences
04-Oct-2023 CTMC partners with ScaleReady to automate, close, and scale for greater patient accessibility ScaleReady
04-Oct-2023 PureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation PureTech Health plc
04-Oct-2023 Foghorn Therapeutics to Present Clinical and Pre-Clinical Data from Multiple Programs Across Its Diverse Pipeline at AACR-NCI-EORTC International Conference Foghorn Therapeutics
04-Oct-2023 Myricx Expands its ADC Expertise with the Appointment of Francesca Zammarchi as CSO Myricx
04-Oct-2023 Rejuvenate Biomed announces positive results from Phase 1b clinical trial with RJx-01 in sarcopenia Rejuvenate Biomed NV
04-Oct-2023 Eurofins CDMO Alphora Inc. (Canada) Announces the Launch of its Biologics Initiative focusing on mAbs and Therapeutic Proteins Businesswire
04-Oct-2023 CellProthera completes enrollment in Phase I/IIB trial for post-myocardial infarction cell therapy CellProthera
04-Oct-2023 IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting IO Biotech
04-Oct-2023 ViroCell expands business development team to support next phase of growth ViroCell
04-Oct-2023 Velocity opens three UK greenfield clinical research sites Velocity
04-Oct-2023 Novotech Appoints Dr. Judith Ng-Cashin as Chief Medical Officer to Drive Global Medical Services Novotech
04-Oct-2023 Advent International and Warburg Pincus Complete Acquisition of Baxter’s BioPharma Solutions Business Advent International
04-Oct-2023 Atriva Therapeutics Announces Publication of Proof of Concept (POC) / Phase 2a RESPIRE Study Data with Zapnometinib in Patients Hospitalized with COVID-19 B3C newswire
04-Oct-2023 XiltriX North America Announces SOC 2 Type 1 Certification for Enhanced Security and Compliance of Its Monitoring-as-a-Service Solution Newswire
04-Oct-2023 Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania Mainz BioMed N.V.
04-Oct-2023 Philippe Coune promoted to Partner at Executive Insight Healthcare Consultants Executive Insight AG
04-Oct-2023 Vacina contra dengue da Takeda recomendada pelo Grupo Consultivo da Organização Mundial da Saúde para introdução em áreas de alta carga e transmissão de dengue em crianças de 6 a 16 anos Businesswire
04-Oct-2023 Takedas Dengue-Impfstoff von der Beratungsgruppe der Weltgesundheitsorganisation zur Einführung in Gebieten mit hoher Dengue-Belastung und -Übertragung bei Kindern im Alter von sechs bis 16 Jahren empfohlen Businesswire
04-Oct-2023 Elixir Medical Completes Submission of DynamX Coronary Bioadaptor System to Japan’s PMDA Agency for Regulatory Approval Businesswire